Acute Kidney Injury Clinical Trial
Official title:
"Early" and "Late" Timing Indication for Starting Renal Replacement Therapy in Acute Renal Failure After Cardiac Surgery: a Prospective, Controlled, Interventional, Single-center Trial
The question of timing of initiation of renal replacement therapy (RRT), "early" versus "late", has seldom been the focus of high-quality or rigorous evaluation. As a consequence, initiatives aimed at identifying the "optimal timing of initiation of RRT" in acute kidney injury (AKI) have been given the highest priority for investigation by the Acute Kidney Injury Network (AKIN). Accordingly, the investigators conducted a prospective, controlled, interventional trial, comparing two treatment groups in which the only variable was the RRT initiation strategy, to determine whether "early" versus "late" initiation in patients with AKI after cardiac surgery is associated with a survival benefit or more favorable outcomes.
Acute kidney injury after cardiac surgery is strongly associated with in-hospital mortality
and morbidity. This is an area where effective treatments are lacking and trial are
difficult to perform. To date no randomized controlled trial (RCT) has sufficiently
estimated the impact of RRT timing of initiation on patient outcome, and the present
prospective, controlled, interventional, single-center trial attempts to compare patient
outcome with "early" versus "late" initiation of RRT. Previous studies in cardiac surgery
setting have been retrospective ones and have been hampered by lead-time bias, and drop out
patients. To overcome these biases all patients who underwent cardiac surgery were
prospectively enrolled in the trial and were divided in two treatment groups: the "early"
approach was used during the first 10-months, and the "late" approach during the next
10-months. To improve the information gained from this non-classical randomized study and to
minimize bias, the investigators enrolled almost all patients with few exclusion criteria
during two following short periods, used intention-to-treat analysis and treated all
patients according to local protocols and international guidelines, except for RRT
initiation strategy.
Outcome parameters were hospital mortality, and ICU and hospital length of stay.
"Early" therapy was started after 6 hours of urine output of less than<0,5ml/Kg/h, whereas
in the "late" group RRT therapy was started on the basis of persistent (lasting more than 12
hours) oliguria.
Data obtained from the database were analyzed using "Statistical Package for Social Science"
(SPSS Inc, Chicago, IL). Continuous variables are presented as mean±SD, categorical
variables were summarized as frequencies and percentages. The Student t test or Pearson X
square test were performed to evaluate differences between groups and to analyze subgroups.
For statistics, a p<0.05 was considered significant.
Power calculation was based on previous reports13 on cumulative mortality following cardiac
surgery. 50% reduction of mortality was hypothesized when the more conservative approach to
cardiac surgery-AKI was applied. The suggested number of patients was about 900 patients per
group.
The main limitation of the present study include the non-classical randomization,
nevertheless we conducted an interventional trial comparing two treatment strategies in two
different groups of patients, prospectively followed and suitable for both treatments.
;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05538351 -
A Study to Support the Development of the Enhanced Fluid Assessment Tool for Patients With Acute Kidney Injury
|
||
| Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
| Completed |
NCT03938038 -
Guidance of Ultrasound in Intensive Care to Direct Euvolemia
|
N/A | |
| Recruiting |
NCT05805709 -
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
|
N/A | |
| Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|
||
| Recruiting |
NCT05897840 -
Continuous Central Venous Oxygen Saturation Measurement as a Tool to Predict Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients
|
N/A | |
| Recruiting |
NCT04986137 -
Fractional Excretion of Urea for the Differential Diagnosis of Acute Kidney Injury in Cirrhosis
|
||
| Terminated |
NCT04293744 -
Acute Kidney Injury After Cardiac Surgery
|
N/A | |
| Completed |
NCT04095143 -
Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
|
||
| Not yet recruiting |
NCT06026592 -
Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
|
||
| Not yet recruiting |
NCT06064305 -
Transcriptional and Proteomic Analysis of Acute Kidney Injury
|
||
| Terminated |
NCT03438877 -
Intensive Versus Regular Dosage For PD In AKI.
|
N/A | |
| Terminated |
NCT03305549 -
Recovery After Dialysis-Requiring Acute Kidney Injury
|
N/A | |
| Completed |
NCT05990660 -
Renal Assist Device (RAD) for Patients With Renal Insufficiency Undergoing Cardiac Surgery
|
N/A | |
| Completed |
NCT04062994 -
A Clinical Decision Support Trial to Reduce Intraoperative Hypotension
|
||
| Terminated |
NCT02860130 -
Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)
|
Phase 3 | |
| Completed |
NCT06000098 -
Consol Time and Acute Kidney Injury in Robotic-assisted Prostatectomy
|
||
| Not yet recruiting |
NCT05548725 -
Relation Between Acute Kidney Injury and Mineral Bone Disease
|
||
| Completed |
NCT02665377 -
Prevention of Akute Kidney Injury, Hearttransplant, ANP
|
Phase 3 | |
| Terminated |
NCT03539861 -
Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients
|
N/A |